UPDATED Apr 16, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$414.58 | -2.7% | 43.8% | US$3.1t | US$471.09 | PE37.3x | E12.6% | 0.7% | Software | ||
AAPL | US$169.38 | -0.2% | 1.7% | US$2.7t | US$199.92 | PE25.9x | E4.8% | 0.6% | Tech | ||
GOOGL | US$154.40 | -1.4% | 47.8% | US$1.9t | US$166.04 | PE26x | E11.8% | n/a | Media | ||
AMZN | US$183.32 | -1.3% | 79.2% | US$1.9t | US$209.09 | PE62.7x | E22.0% | n/a | Retail | ||
META | US$499.76 | -3.3% | 129.4% | US$1.3t | US$536.15 | PE32.6x | E14.5% | 0.4% | Media | ||
LLY | US$746.74 | -1.4% | 101.9% | US$676.3b | US$812.94 | PE128.4x | E27.1% | 0.7% | Pharmaceuticals & Biotech | ||
AVGO | US$1,329.06 | -0.4% | 110.2% | US$607.4b | US$1,501.55 | PE53.2x | E23.4% | 1.6% | Semiconductors | ||
NOVO B | kr.867.50 | 1.1% | 50.2% | kr.3.9t | kr.904.20 | PE46.3x | E14.8% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$180.80 | -8.3% | 27.9% | US$525.3b | US$205.38 | PB1.7x | E-1.6% | 2.5% | Banks | ||
WMT | US$59.84 | 0.08% | 19.8% | US$482.9b | US$65.08 | PE31.1x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$118.69 | -2.1% | 1.5% | US$473.7b | US$129.14 | PE13x | E-0.7% | 3.2% | Energy | ||
UNH | US$468.89 | 2.0% | -7.1% | US$410.8b | US$570.64 | PE19.3x | E10.0% | 1.6% | Healthcare | ||
A005930 | ₩78,900.00 | -5.6% | 20.5% | ₩532.4t | ₩101,991.89 | PE37x | E27.4% | 1.8% | Tech | ||
PG | US$155.95 | -0.5% | 3.1% | US$365.8b | US$169.59 | PE25.3x | E7.4% | 2.4% | Household | ||
700 | HK$300.80 | -4.3% | -15.8% | HK$2.8t | HK$418.05 | PE22.5x | E15.0% | 1.1% | Media | ||
JNJ | US$144.45 | -5.1% | -10.3% | US$355.7b | US$175.36 | PE26.1x | E10.2% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$334.83 | -7.4% | 12.0% | US$334.9b | US$384.83 | PE21.9x | E4.2% | 2.7% | Retail | ||
ORCL | US$120.62 | -2.1% | 25.0% | US$329.5b | US$137.02 | PE31.2x | E14.9% | 1.3% | Software | ||
MRK | US$125.06 | -1.3% | 8.9% | US$319.6b | US$137.17 | PE867.9x | E25.9% | 2.5% | Pharmaceuticals & Biotech | ||
COST | US$715.97 | -0.4% | 44.1% | US$318.6b | US$768.10 | PE46.7x | E7.5% | 0.6% | Consumer Retailing | ||
CVX | US$156.28 | -3.5% | -8.4% | US$291.1b | US$180.53 | PE13.5x | E2.3% | 4.2% | Energy | ||
600519 | CN¥1,667.00 | 1.2% | -5.2% | CN¥2.1t | CN¥2,154.31 | PE28x | E12.8% | 3.0% | Food, Beverage & Tobacco | ||
ABBV | US$162.54 | -4.5% | 1.8% | US$286.3b | US$184.25 | PE59.7x | E22.7% | 3.8% | Pharmaceuticals & Biotech | ||
BAC | US$34.68 | -8.1% | 13.5% | US$283.7b | US$39.02 | PB1x | E3.7% | 2.8% | Banks |